These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 2085337)

  • 1. [Pharmacokinetics and tolerability of telenzepine in patients with compensated liver cirrhosis].
    Reinicke A; Müller P; Dammann HG; Simon B
    Arzneimittelforschung; 1990 Nov; 40(11):1239-41. PubMed ID: 2085337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of the M1-selective telenzepine on esophageal acid exposure in healthy volunteers.
    Stockbrügger RW; Armbrecht U; Reul W
    Z Gastroenterol; 1988 Jun; 26(6):297-302. PubMed ID: 3061181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral and intravenous pharmacokinetics of cimetidine in liver cirrhosis.
    Okolicsanyi L; Venuti M; Orlando R; Lirussi F; Nassuato G; Benvenuti C
    Int J Clin Pharmacol Ther Toxicol; 1982 Oct; 20(10):482-7. PubMed ID: 7141756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Dose finding study of telenzepine (1.5 vs. 3 vs 5 mg once daily) in acute treatment of duodenal ulcer. A double-blind, randomized, multicenter parallel group comparison].
    Hüttemann W; Schneider A
    Med Klin (Munich); 1989 Dec; 84(12):574-7. PubMed ID: 2695806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Single evening administration of a new antimuscarinic agent telenzepine in therapy of acute duodenal ulcer. Results of a randomized double-blind comparative study versus pirenzepine].
    Dammann HG; Dreyer M; Wolf N; Müller P; Merk-Härtelt B; Simon B
    Z Gastroenterol; 1989 Apr; 27(4):203-6. PubMed ID: 2658396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of telenzepine, an M1-selective muscarinic receptor antagonist, in patients with nocturnal asthma.
    Cazzola M; Matera MG; Liccardi G; Sacerdoti G; D'Amato G; Rossi F
    Pulm Pharmacol; 1994 Apr; 7(2):91-7. PubMed ID: 8081076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [3 mg telenzepine nocte in the treatment of benign stomach ulcer disease: a double-blind comparative study with 300 mg ranitidine nocte].
    Simon B; Reinicke HG; Dammann HG; Müller P
    Z Gastroenterol; 1990 Feb; 28(2):90-3. PubMed ID: 2181788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biotransformation and uric acid lowering effect of benzbromarone in patients with liver cirrhosis - evidence for active benzbromarone metabolites?
    Walter-Sack I; de Vries JX; von Bubnoff A; Pfleilschifter V; Raedsch R
    Eur J Med Res; 1995 Oct; 1(1):16-20. PubMed ID: 9392688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single and repeated dose pharmacokinetics of dexketoprofen trometamol in patients with impaired liver function.
    Valles J; Artigas R; Bertolotti M; Crea A; Muller F; Paredes I; Capriati A
    Methods Find Exp Clin Pharmacol; 2006 Jun; 28 Suppl A():29-36. PubMed ID: 16801990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telenzepine, a new M1-receptor antagonist, is a more potent inhibitor of pentagastrin-stimulated gastric acid output than pirenzepine in dogs.
    Holtmann G; Küppers U; Singer MV
    Scand J Gastroenterol; 1990 Mar; 25(3):293-7. PubMed ID: 2320949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of ciprofloxacin in impaired liver function.
    Esposito S; Miniero M; Barba D; Sagnelli E
    Int J Clin Pharmacol Res; 1989; 9(1):37-41. PubMed ID: 2707924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of telenzepine on gastrointestinal transit: comparison with placebo and domperidone.
    Armbrecht U; Reul W; Stockbrügger RW
    Z Gastroenterol; 1990 Feb; 28(2):85-9. PubMed ID: 2181787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of pirenzepine in patients with gastric or duodenal ulcers.
    Hayakawa A; Misawa T; Nishihara S; Kobayashi S; Bozler G
    Arzneimittelforschung; 1987 Aug; 37(8):980-2. PubMed ID: 3675700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical pharmacokinetics of ibopamine on different diseases and conditions.
    Ventresca GP; Lodola E
    Arzneimittelforschung; 1988 Aug; 38(8):1175-80. PubMed ID: 2904270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of perindopril: therapeutic consequences.
    Lees KR; Hughes DM; McNeill CA; Reid JL
    Clin Exp Hypertens A; 1989; 11 Suppl 2():499-506. PubMed ID: 2605799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of picumast dihydrochloride in patients with liver cirrhosis.
    Neugebauer G; Raedsch R; Stiehl A; Kaufmann B; Besenfelder E; Neubert P; Walter-Sack I
    Arzneimittelforschung; 1989 Oct; 39(10A):1343-7. PubMed ID: 2576360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pharmacokinetics of H2 receptor blocking agents in compensated liver cirrhosis.
    Okolicsányi L; Venuti M; Strazzabosco M; Iemmolo RM; Nassuato G; Orlando R; Lirussi F
    Acta Physiol Hung; 1984; 64(3-4):393-400. PubMed ID: 6099684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of oral lidocaine and nifedipine in patients with liver cirrhosis.
    Tonsuwannont W; Praisontarangkul OA; Manorot M; Klangwarnwong D
    J Med Assoc Thai; 1996 May; 79(5):309-19. PubMed ID: 8708523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-dose pharmacokinetics of nateglinide in subjects with hepatic cirrhosis.
    Choudhury S; Hirschberg Y; Filipek R; Lasseter K; McLeod JF
    J Clin Pharmacol; 2000 Jun; 40(6):634-40. PubMed ID: 10868314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Famotidine pharmacokinetics following oral and intravenous administration in patients with liver disease: results of a preliminary study.
    Morgan MY; Stambuk D
    Postgrad Med J; 1986; 62 Suppl 2():29-37. PubMed ID: 2890149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.